Assessment of the external validity of National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non-Small Cell Lung Cancer in a population of elderly patients aged 80 and older.

Nicolo Matteo Luca Battisti; Marina Sehovic; Martine Extermann

doi:10.1200/jco.2015.33.15_suppl.e20539

Assessment of the external validity of National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non-Small Cell Lung Cancer in a population of elderly patients aged 80 and older.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e20539 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e20539-e20539 ◽

Cited By ~ 1

Author(s):

Nicolo Matteo Luca Battisti ◽

Marina Sehovic ◽

Martine Extermann

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

National Comprehensive Cancer Network ◽

European Society ◽

External Validity ◽

Medical Oncology ◽

Small Cell ◽

Small Cell Lung ◽

Cancer Network ◽

Aged 80 And Older

Download Full-text

Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non–Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older

Clinical Lung Cancer ◽

10.1016/j.cllc.2017.03.005 ◽

2017 ◽

Vol 18 (5) ◽

pp. 460-471 ◽

Cited By ~ 10

Author(s):

Nicolò Matteo Luca Battisti ◽

Marina Sehovic ◽

Martine Extermann

Keyword(s):

Lung Cancer ◽

National Comprehensive Cancer Network ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

European Society ◽

External Validity ◽

Medical Oncology ◽

Small Cell ◽

Small Cell Lung ◽

Cancer Network

Download Full-text

Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009

Thoracic Cancer ◽

10.1111/j.1759-7714.2010.00016.x ◽

2010 ◽

Vol 1 (2) ◽

pp. 83-86 ◽

Cited By ~ 6

Author(s):

Yan Xu ◽

Hongyu Liu ◽

Jun Chen ◽

Qinghua Zhou

Keyword(s):

Lung Cancer ◽

Clinical Practice ◽

Clinical Practice Guidelines ◽

Practice Guidelines ◽

European Society ◽

Medical Oncology ◽

Small Cell ◽

Small Cell Lung ◽

Cancer Network ◽

Original Edition

Download Full-text

PCN121 ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASE

Value in Health ◽

10.1016/j.jval.2011.02.975 ◽

2011 ◽

Vol 14 (3) ◽

pp. A176-A177

Author(s):

E.M. Lepisto ◽

J.L. Vandergrift ◽

G.P. Kalemkerian ◽

K.M. Pisters ◽

C. Zornosa ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Practice ◽

National Comprehensive Cancer Network ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Small Cell ◽

Small Cell Lung ◽

Federal Drug Administration ◽

Medication Utilization ◽

Cancer Network

Download Full-text

Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancer

Current Oncology ◽

10.3747/co.v17i6.795 ◽

2010 ◽

Vol 17 (6) ◽

Cited By ~ 1

Author(s):

V. Hirsh

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

European Society ◽

Medical Oncology ◽

Small Cell ◽

Small Cell Lung

Download Full-text

Use of Adjuvant Chemotherapy (CT) and Radiotherapy (RT) in Incompletely Resected (R1) Early Stage Non-Small Cell Lung Cancer (NSCLC): A European Survey Conducted by The European Society for Medical Oncology (ESMO) Young Oncologists Committee

Annals of Oncology ◽

10.1016/s0923-7534(20)33746-7 ◽

2012 ◽

Vol 23 ◽

pp. ix386-ix387

Author(s):

R. Califano

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

European Society ◽

Medical Oncology ◽

Early Stage ◽

Small Cell ◽

Small Cell Lung ◽

European Survey

Download Full-text

First-line systemic therapy in metastatic non-small cell lung cancer (mNSCLC) patients treated at National Comprehensive Cancer Network (NCCN) institutions: An analysis from the NCCN Oncology Outcomes Database Project.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7634 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7634-7634

Author(s):

J. L. Vandergrift ◽

R. Mamet ◽

C. Zornosa ◽

M. E. Reid ◽

M. S. Rabin ◽

...

Keyword(s):

Lung Cancer ◽

National Comprehensive Cancer Network ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Systemic Therapy ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Cancer Network

Download Full-text

Utilization of adjuvant therapy among completely resected non-small cell lung cancer (NSCLC) patients in the National Comprehensive Cancer Network (NCCN) Outcomes Database Project.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7017 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7017-7017 ◽

Cited By ~ 2

Author(s):

C. Zornosa ◽

R. Mamet ◽

M. E. Reid ◽

D. S. Ettinger ◽

G. A. Otterson ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

National Comprehensive Cancer Network ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Nsclc Patients ◽

Cancer Network

Download Full-text

Comparison of National Comprehensive Cancer Network and American College of Surgeons Commission on Cancer Lymph Node Sampling Guidelines for Non-Small Cell Lung Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2021.10.171 ◽

2022 ◽

Vol 112 (2) ◽

pp. e6

Author(s):

B. Heiden ◽

D. Eaton ◽

S.H. Chang ◽

Y. Yan ◽

M. Schoen ◽

...

Keyword(s):

Lung Cancer ◽

Lymph Node ◽

National Comprehensive Cancer Network ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lymph Node Sampling ◽

American College Of Surgeons ◽

Cancer Network

Download Full-text

Checkpoint inhibitors for the treatment of non-small-cell lung cancer: news from the 2016 European Society for Medical Oncology Annual Congress

Drugs & Therapy Perspectives ◽

10.1007/s40267-016-0369-3 ◽

2016 ◽

Vol 33 (3) ◽

pp. 126-132

Author(s):

Martin Chopra

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

European Society ◽

Medical Oncology ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Annual Congress

Download Full-text

A phase II randomized, placebo-controlled trial evaluating nintedanib versus placebo as prophylaxis against radiation pneumonitis in patients with unresectable non-small cell lung cancer (NSCLC ) undergoing chemoradiation therapy (CRT): A National Comprehensive Cancer Network-sponsored study.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.tps8572 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS8572-TPS8572

Author(s):

Grace K. Dy ◽

Eric S. Kim ◽

Megan Ann Baumgart ◽

Malcolm Mattes ◽

Patrick C. Ma ◽

...

Keyword(s):

Lung Cancer ◽

National Comprehensive Cancer Network ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Radiation Pneumonitis ◽

Controlled Trial ◽

Small Cell ◽

Chemoradiation Therapy ◽

Small Cell Lung ◽

Cancer Network

Download Full-text